S&P 500
2078.52
+7.87 +0.38%
Dow Indu
17960.71
+155.91 +0.88%
Nasdaq
4781.61
+16.23 +0.34%
Crude Oil
55.28
-1.85 -3.20%
Gold
1174.550
-23.460 -1.96%
Euro
1.224120
-0.000345 -0.03%
US Dollar
89.745
+0.229 +0.29%
Weak

Chicago Board of TradeT-BONDS Mar 2013 (E) (CBOT:ZB.H13.E)

145.21875 +1.00000 (+0.69%)

2013-03-19 17:15:19, 10 min delay

T-BONDS Mar 2013 (E) (CBOT:ZB.H13.E) Future Chart
1 Day
3 Day
5 Day
1 Month
3 Month
6 Month
1 Year
Max
Last Price145.21875
Settle Time17:15
Previous Close145.21875
Low144.03125
Time2013-03-19 17:15:19
Contract High Date2012-07-16
Contract Low Date2013-03-08
Expiration2013-03-19
Close Time17:00
Net Change1.00000
Open144.18750
High145.18750
Open Int.5471
Contract High152.03125
Contract Low142
First Delivery2013-03-28
Open Time18:00

Today's Top 50 Trending Stocks: Let our SmartScan and Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly rank today's top 50 stocks for you. This complimentary list will update throughout the day to highlight the most timely trading opportunities.

First Name
Last Name
Email
 
By filling out the form, you'll receive instant access to Today's Top 50 Trending Stocks list and other trading resources from INO.com.

List of Top Stocks


Trader's Blog

The 5 Keys To Trading And The 1 Key To Your Success
   3 hours ago
10 Days Left - MarketClub Holiday Membership Rate
   1 day ago
Sterling Back in the Game?
   1 day ago

Today's Financial News

Oil patch officials say drilling downturn won't slow housing, infrastructure demands

4 hours ago

BISMARCK, N.D. (AP) — City officials in the North Dakota oil patch say they are forging ahead with housing and infrastructure projects, despite an expected downturn in drilling in the next year. "Basically, based on projections for a need of 7,000 permanent housing units, we're only at about 2,000," Sanford said. "We're so far away. We can't let our foot off the pedal here."

Achillion rises as company says combo of hepatitis C drugs cured all patients in small study

4 hours ago

NEW YORK (AP) — Shares of Achillion Pharmaceuticals advanced Monday after the company said a combination of two experimental hepatitis C drugs cured all patients in a small clinical trial. Shares of Achillion Pharmaceuticals Inc. climbed $1.56, or 11 percent, to $15.77 in morning trading. Earlier the stock rose to $16.74, its highest price in almost eight years.

Express Scripts to shift coverage away from pricey hepatitis C drugs like Sovaldi

4 hours ago

The nation's largest pharmacy benefits manager is throwing its weight into a fight over the high cost of treating hepatitis C, saying it will cover a new drug from AbbVie while pulling back on more expensive options from rival drugmakers. Express Scripts will still cover the other drugs if patients have already started treatment or if the patient has a clinical exception and needs those particular drugs.

Correction: Marijuana Research story

4 hours ago

DENVER (AP) — In a story Dec. 17 about marijuana research, The Associated Press reported erroneously reported Marcel Bonn-Miller's profession. He is a psychologist, not a psychiatrist. Also, while he works with the Veterans Administration, his lab is not part of the VA. Colorado funds medical marijuana research, a first

INO.com on Facebook INO.com MarketClub on Twitter INO.com on Google+ INO.com YouTube

© Copyright INO.com, Inc. All Rights Reserved.